← Back
$XFOR All transactions

X4 Pharmaceuticals, Inc

A

$ Value

$0

Shares

3,333

Price

$0

Filed

Jul 3

Insider

Name

Thoren Natasha Fay

Title

Chief Legal Officer

CIK

0002070977

Roles

Officer

Transaction Details

Transaction Date

2025-05-20

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

9,462

Footnotes

Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in three equal annual installments on May 10, 2026, May 10, 2027 and May 10, 2028, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date. | The reported amount has been adjusted to reflect a correction to the number of shares beneficially owned by the Reporting Person, which was inadvertently overstated by 855 shares on the Form 3 filed on June 3, 2025.

Filing Info

Accession No.

0001628280-25-034233

Form Type

4

Issuer CIK

0001501697

Thoren Natasha Fay's History

Date Ticker Type Value
2025-05-20 XFOR A $0

Other Insiders at XFOR (90d)

No other insider activity at this issuer in the last 90 days.